These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9791881)

  • 1. [Dynamics of immunologic indicators in guinea pigs upon administering various preparations of the Ebola virus].
    Dadaeva AA; Sizikova LP; Zhukov VA; Chepurnov AA
    Vopr Virusol; 1998; 43(4):163-9. PubMed ID: 9791881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of an infections dose of the Ebola virus on survivability and immunologic indicators in guinea pigs].
    Dadaeva AA; Chepurnov AA; Sizikova LP; Chepurnova TS
    Vopr Virusol; 1999; 44(5):217-20. PubMed ID: 10544449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Change in biochemical and hemostatic indicators in guinea pigs upon administering Ebola virus preparations].
    Chepurnov AA; Dadaeva AA; Zhukov VA; Sizikov LP; Merzlikin NV
    Vopr Virusol; 1997; 42(4):171-5. PubMed ID: 9304298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of repeated administration of Ebola virus preparations on dynamics of immunologic parameters].
    Chepurnov AA; Dadaeva AA; Sizikova LP
    Biull Eksp Biol Med; 1999 Jan; 127(1):81-5. PubMed ID: 10190013
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.
    Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamics of complement hemolytic activity in experimental Ebola infection].
    Zabavichene NM; Chepurnov AA
    Vopr Virusol; 2004; 49(2):21-5. PubMed ID: 15106379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunobiological properties of vp24 protein of Ebola virus expressed by recombinant vaccinia virus].
    Chepurnov AA; Ternovoĭ VA; Dadaeva AA; Dmitriev IP; Sizikova LP; Volchkov VE; Kudoiarova NM; Rudzevich TN; Netesov SV
    Vopr Virusol; 1997; 42(3):115-20. PubMed ID: 9297340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge.
    Bukreyev A; Yang L; Zaki SR; Shieh WJ; Rollin PE; Murphy BR; Collins PL; Sanchez A
    J Virol; 2006 Mar; 80(5):2267-79. PubMed ID: 16474134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attempts to develop a vaccine against Ebola fever].
    Chupurnov AA; Chernukhin IV; Ternovoĭ VA; Kudoiarova NM; Makhova NM; Azaev MSh; Smolina MP
    Vopr Virusol; 1995; 40(6):257-60. PubMed ID: 8686261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation in nonhuman primates of vaccines against Ebola virus.
    Geisbert TW; Pushko P; Anderson K; Smith J; Davis KJ; Jahrling PB
    Emerg Infect Dis; 2002 May; 8(5):503-7. PubMed ID: 11996686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematological and immunological parameters during Ebola virus passages in guinea-pigs].
    Dadaeva AA; Sizikova LP; Subbotina EL; Chepurnov AA
    Vopr Virusol; 2006; 51(4):32-7. PubMed ID: 16929596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of experimental Ebola virus infection in guinea pigs.
    Connolly BM; Steele KE; Davis KJ; Geisbert TW; Kell WM; Jaax NK; Jahrling PB
    J Infect Dis; 1999 Feb; 179 Suppl 1():S203-17. PubMed ID: 9988186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus.
    Bray M; Hatfill S; Hensley L; Huggins JW
    J Comp Pathol; 2001 Nov; 125(4):243-53. PubMed ID: 11798241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the phagocytic ability of blood polymorphonuclear leukocytes from rabbits and guinea pigs upon administering Ebola virus].
    Dadaveva AA; Sizikova LP; Bakulina LF; Chepurnov AA
    Vopr Virusol; 1997; 42(2):56-9. PubMed ID: 9182399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune and pathophysiological processes in baboons experimentally infected with Ebola virus adapted to guinea pigs.
    Ignatiev GM; Dadaeva AA; Luchko SV; Chepurnov AA
    Immunol Lett; 2000 Feb; 71(2):131-40. PubMed ID: 10714441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization for Ebola virus infection.
    Xu L; Sanchez A; Yang Z; Zaki SR; Nabel EG; Nichol ST; Nabel GJ
    Nat Med; 1998 Jan; 4(1):37-42. PubMed ID: 9427604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Developing methods of specific heterologic immunoglobulins preparation for urgent prevention of Ebola fever and study of their properties].
    Cherpunov AA; Kudoiarova-Zubavichene NM; Dedkova LM; Sergeev NN; Netesov SV
    Vestn Ross Akad Med Nauk; 1998; (4):24-9. PubMed ID: 9633237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola virus transmission in guinea pigs.
    Wong G; Qiu X; Richardson JS; Cutts T; Collignon B; Gren J; Aviles J; Embury-Hyatt C; Kobinger GP
    J Virol; 2015 Jan; 89(2):1314-23. PubMed ID: 25392221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola takes a punch.
    Folks T
    Nat Med; 1998 Jan; 4(1):16-7. PubMed ID: 9427596
    [No Abstract]   [Full Text] [Related]  

  • 20. Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals.
    Wong G; Richardson JS; Cutts T; Qiu X; Kobinger GP
    Antiviral Res; 2015 Apr; 116():17-9. PubMed ID: 25596432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.